HCPCS code G6057
Phenothiazine
What G6057 means
G6057 (Assay of phenothiazine) belongs to the HCPCS Level II G series (Procedures / Professional Services (Temporary)). Its Medicare coverage status is Carrier judgment. Medicare coverage is left to the judgment of the local Medicare Administrative Contractor (MAC), so check your MAC's local coverage determinations.
Part B pricing: Price subject to national limitation amount.
Code details
- Short description
- Assay of phenothiazine
- Coverage code
- C = Carrier judgment
- Pricing indicator
- 21 = Price subject to national limitation amount
- Multiple pricing indicator
- A = Not applicable as HCPCS priced under one methodology
- Type of service
- 5 = Diagnostic laboratory
- Action code
- N = No maintenance for this code
- Action effective date
- January 01, 2016
- Code added date
- January 01, 2015
- Data year
- 2026
Questions about G6057
What is HCPCS code G6057?
HCPCS code G6057 is a Level II code in the G series (Procedures / Professional Services (Temporary)). Its full description is: "Phenothiazine"
Is G6057 a CPT code?
No. G6057 is a HCPCS Level II code maintained by CMS, not a CPT (Level I) code from the American Medical Association. People often search for it as a CPT code because both code sets are reported on the same claims.
Does Medicare cover HCPCS code G6057?
The Medicare coverage code for G6057 is "Carrier judgment". Medicare coverage is left to the judgment of the local Medicare Administrative Contractor (MAC), so check your MAC's local coverage determinations.
When was HCPCS code G6057 added?
G6057 was added to the HCPCS code set on January 01, 2015. The most recent action on it (No maintenance for this code) took effect on January 01, 2016.
Nearby G codes
All G codes- G6052Meprobamate
- G6053Methadone
- G6054Methsuximide
- G6055Nicotine
- G6056Opiate(s), drug and metabolites, each procedure
- G6058Drug confirmation, each procedure
- G8126Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
- G8127Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
- G8128Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure
- G8395Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function